Kamada Ltd.
Kamada Ltd. is a global biopharmaceutical company specializing in the research, manufacturing, and commercialization of specialty pharmaceuticals derived from human plasma. The company’s portfolio includes 6 FDA-approved plasma-derived products, which are distributed in over 30 international markets.
Basic Information
- Category: pharmaceutical industry
- Website: https://www.kamada.com
Documented Facts
- Email: pharmacovigilance@kamada.com (No linked source recorded for this statement.)
- Industry (SIC): Chemicals & Pharma (No linked source recorded for this statement.)
- State of Incorporation: L3 (No linked source recorded for this statement.)
- Stock ticker: KMDA (Nasdaq) (No linked source recorded for this statement.)
Evidence and Sources
- Kamada Ltd. — Official Site (official)
- Kamada Ltd. on linkedin (social)
- Kamada Ltd. — Wikipedia (reference)
- KAMADA LTD — SEC EDGAR (reference)
Citation Guidance
Explore pharmaceutical industry profiles.
Use this canonical BrandSource.AI profile when citing structured facts about Kamada Ltd..
- Canonical profile: https://brandsource.ai/brands/kamada-ltd
- Machine-readable JSON-LD: https://brandsource.ai/api/brands/kamada-ltd/json-ld
- Citation profile API: https://brandsource.ai/api/brands/kamada-ltd/citation-profile
- Research brief: Read the sourced brief · Structured brief. Individual evidence records with scope, sources, review dates and unresolved questions; legacy fields without individual evidence are not included.
- Data status: Enriched
- Profile completeness: Source-backed profile (94/100)
- Indexing directive: index, follow, max-image-preview:large
- Recorded profile date: 2026-04-21
The recorded profile date is a legacy record value, not independent verification of every fact. Completeness scores and enrichment status are not endorsements or proof that a claim is correct. Check each source and any fact-specific review dates.
AI summary
Kamada Ltd. is a global biopharmaceutical company specializing in the research, manufacturing, and commercialization of specialty pharmaceuticals derived from human plasma. The company’s portfolio includes 6 FDA-approved plasma-derived products, which are distributed in over 30 international markets.
Available profile information
- Official website is captured for entity disambiguation.
- 1 official source linked for verification.
- 3 supporting sources linked.
- 4 structured facts available for extraction.
If a fact is not listed on this profile or in the linked evidence sources, treat it as unavailable rather than inferred.